Literature DB >> 21886388

Clinical Features of Bone Complications and Prognostic Value of Bone Lesions Detected by X-ray Skeletal Survey in Previously Untreated Patients with Multiple Myeloma.

Si-Dan Li, Ya-Fei Wang, Jun-Yuan Qi, Lu-Gui Qiu.   

Abstract

Multiple myeloma is usually associated with the presence of lytic bone lesions. We reviewed the clinical and laboratory features of patients with newly diagnosed myeloma bone disease and evaluated the prognostic significance of different X-ray image patterns in symptomatic MM patients. We retrospectively reviewed 260 patients with newly diagnosed MM. X-ray image patterns of patients were correlated with hematologic parameters, therapeutic reaction and patient survival. Patients with the X-ray imaging pattern of grade 2-4 had significantly higher marrow plasma cells levels, marrow CD138(+) D38(+) cell percentage, ECOG performance score, and serum IL-6 level than grade 0-1. Univariate analysis demonstrated that skeletal lytic changes associated with rapid progression. There is a high incidence of myeloma bone disease (MBD) in patients of MM in China. Patients of extensive bone lesions have more severe alterations in hematologic parameters than do those without bone lesions and severe bone lesions is an important adverse prognostic factor associated with a short TTP.

Entities:  

Keywords:  Bone lesions; Multiple myeloma; Myeloma bone disease; Prognosis

Year:  2010        PMID: 21886388      PMCID: PMC3002090          DOI: 10.1007/s12288-010-0033-3

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  19 in total

1.  Variations in the roentgen appearance of the skeletal system in myeloma.

Authors:  S HEISER; J J SCHWARTZMAN
Journal:  Radiology       Date:  1952-02       Impact factor: 11.105

2.  VAD-based regimens as primary treatment for multiple myeloma.

Authors:  R Alexanian; B Barlogie; S Tucker
Journal:  Am J Hematol       Date:  1990-02       Impact factor: 10.047

Review 3.  [Prognostic significance of skeletal lesions in multiple myeloma].

Authors:  R Bettini; P Anzani; C M Quadrelli; S Mammano; P Rapazzini; E Marrapodi; V Sessa
Journal:  Recenti Prog Med       Date:  1989-06

4.  Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease.

Authors:  Aikaterini Sfiridaki; Spiros Miyakis; George Tsirakis; Athanassios Alegakis; Andreas M Passam; Ermioni Kandidaki; Andrew N Margioris; Michael G Alexandrakis
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

5.  The prognostic significance of X-ray changes at presentation and reassessment in patients with multiple myeloma.

Authors:  D B Smith; J H Scarffe; B Eddleston
Journal:  Hematol Oncol       Date:  1988 Jan-Mar       Impact factor: 5.271

6.  The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group.

Authors:  D Tong; L Gillick; F R Hendrickson
Journal:  Cancer       Date:  1982-09-01       Impact factor: 6.860

7.  International staging system for multiple myeloma.

Authors:  Philip R Greipp; Jesus San Miguel; Brian G M Durie; John J Crowley; Bart Barlogie; Joan Bladé; Mario Boccadoro; J Anthony Child; Herve Avet-Loiseau; Jean-Luc Harousseau; Robert A Kyle; Juan J Lahuerta; Heinz Ludwig; Gareth Morgan; Raymond Powles; Kazuyuki Shimizu; Chaim Shustik; Pieter Sonneveld; Patrizia Tosi; Ingemar Turesson; Jan Westin
Journal:  J Clin Oncol       Date:  2005-04-04       Impact factor: 44.544

8.  Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging.

Authors:  F E Lecouvet; B C Vande Berg; L Michaux; J Malghem; B E Maldague; J Jamart; A Ferrant; J L Michaux
Journal:  Radiology       Date:  1998-12       Impact factor: 11.105

9.  A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Authors:  B G Durie; S E Salmon
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

10.  Quantification of bone lytic lesions and prognosis in myelomatosis.

Authors:  A de Gramont; O Benitez; P Brissaud; M Krulik; D Hubert; A Sirinelli; N Smadja; J Debray
Journal:  Scand J Haematol       Date:  1985-01
View more
  2 in total

1.  Loss expression of micro ribonucleic acid (miRNA)-200c induces adverse post-surgical prognosis of advanced stage non-small cell lung carcinoma and its potential relationship with ETAR messenger RNA.

Authors:  Jinpeng Zhao; Yandong Zhao; Zizong Wang; Yunpeng Xuan; Yiren Luo; Wenjie Jiao
Journal:  Thorac Cancer       Date:  2015-07-02       Impact factor: 3.500

2.  Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis.

Authors:  Mu Hao; Meirong Zang; Lei Zhao; Shuhui Deng; Yan Xu; Fang Qi; Gang An; Yu Qin; Weiwei Sui; Fei Li; Wenjuan Yang; Zengjun Li; Shuhua Yi; Dehui Zou; Fenghuang Zhan; Lugui Qiu
Journal:  Oncotarget       Date:  2016-04-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.